Find Academic Supervisors

• Diabetes research
• Pancreatic islet biology
• Growth factors
• +5 more

Dr. Jun-Li Liu is an Associate Professor in the Department of Medicine, Faculty of Medicine and Health Sciences at McGill University, and a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site. She is affiliated with the Metabolic Disorders and Complications Program within the Centre for Translational Biology, focusing on diabetes research and pancreatic islet biology. Dr. Liu's educational background includes: BSc in Biology from Peking University, China (1978-1982) MSc in Physiology from Peking University Health Science Centre, China (1982-1985) PhD in Experimental Medicine from McGill University, Montreal, Canada (1990-1995) Postdoctoral fellowship at the National Institutes of Health, NIDDK, Bethesda, MD (1995-2000) Dr. Liu's research focuses on exploring novel growth factors that can be used to expand or preserve islet beta cells, which produce insulin, to prevent or treat diabetes mellitus. Her current work centers on CCN5/WISP2 and Reg family proteins normally produced in the pancreas, which have shown promise in rodent models of diabetes. Her laboratory investigates how these proteins promote beta-cell proliferation, survival, and regeneration through mechanisms including activation of signaling molecules like Akt and Erk1/2 kinases. The ultimate goal is to develop novel therapeutic approaches for diabetes treatment by exploiting these growth factors and their molecular targets. Her recent publications demonstrate a consistent focus on pancreatic islet biology, with particular emphasis on CCN5/WISP2 and Reg family proteins. These works span molecular mechanisms of beta-cell growth and survival, connections to diabetes pathogenesis, and potential translational applications. A significant theme across her work is understanding how growth factors might be harnessed for diabetes therapy, with implications for both type 1 and type 2 diabetes. Dr. Liu has received numerous scientific awards and recognitions throughout her career: Fellowship award from Medical Research Council of Canada (1996-1999) New Investigator Award from The Endocrine Society (1998) Fellows Award for Research Excellence from NIH (1999) Career Development Award from Juvenile Diabetes Research Foundation International (2000-2005) Travel Grant Award from The Endocrine Society (2001) John R. & Clara M. Fraser Memorial Award from McGill University (2005-2008) Chercheurs boursiers Fondamental, Senior, from Fonds de la recherché en santé Quebec (2008-2011) Dr. Liu has served on the editorial boards of the Journal of Diabetes (Blackwell Publishing) since 2008 and the Canadian Journal of Diabetes since 2017. She is also a member of the Montreal Diabetes Research Centre. Her research has been supported by various funding agencies, including the Juvenile Diabetes Research Foundation International and the Medical Research Council of Canada. She has mentored numerous graduate students and postdoctoral fellows in her laboratory. Dr. Liu leads a research laboratory at the RI-MUHC focused on pancreatic islet biology and diabetes research. Her team employs molecular, cellular, and in vivo approaches using transgenic and knockout mouse models to investigate the mechanisms by which growth factors regulate beta-cell mass and function. Current projects include studying CCN5/WISP2 and Reg family proteins in beta-cell proliferation, survival, and regeneration, with implications for diabetes therapy. They also investigate the role of Reg proteins in pancreatic ductal adenocarcinoma, exploring their potential as diagnostic markers and therapeutic targets.

• Critical Care Medicine
• Risk Prediction in ICU
• Chronic Critical Illness
• +4 more

Jason Shahin is an Assistant Professor at the Department of Medicine , Faculty of Medicine and Health Sciences , McGill University . He serves as an Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) , specifically within the Translational Research in Respiratory Diseases Program . His academic and clinical work bridges critical care medicine and respiratory medicine at the McGill University Health Centre (MUHC) . Research Focus: Dr. Shahin specializes in risk prediction in intensive care units (ICU) , with particular emphasis on prediction tools for complex populations , including the chronic critically ill and potential organ donors . His work integrates clinical data science with translational approaches to improve ICU outcomes. Article Trends: His publications span critical care medicine , sepsis , mechanical ventilation , and organ donation . Recent studies focus on machine learning applications , probiotics in infection prevention , and blood conservation strategies in ICU settings. Key Collaborations: He contributes to large-scale trials like the LOVIT , PROSPECT , and FORECAST studies, collaborating with networks such as the Canadian Critical Care Trials Group and REVA Network .

• Photonics
• Biophotonics
• Optical Microscopy
• +3 more

Dr. Wolfgang Hübner is a Researcher at the Faculty of Physics at University of Bielefeld, Germany, affiliated with the Biomolecular Photonics Group. His work focuses on advanced optical imaging techniques applied to cellular and molecular structures. He maintains an active research program as evidenced by numerous publications from 2023-2025. His research interests center on photonics, biophotonics, optical microscopy, super-resolution imaging techniques, cellular biophysics, and molecular imaging. Dr. Hübner's work bridges physics and biology, developing and applying cutting-edge microscopy methods to address biological questions at the nanoscale level. His recent publications demonstrate a strong focus on super-resolution microscopy techniques, particularly structured illumination microscopy, fluorescence lifetime imaging, and correlative imaging approaches. His research investigates cellular structures like liver sinusoidal endothelial cells, dystroglycan mutants, and mitochondrial dynamics, revealing how advanced optical methods can visualize biological processes at unprecedented resolution. Dr. Hübner's research shows consistent development in both methodological advances in optical imaging and biological applications. His work spans from fundamental optical engineering to biomedical applications, demonstrating interdisciplinary expertise across physics, engineering, and cell biology.

• Pharmacokinetics
• Pharmacodynamics
• Intravenous Anesthetics
• +3 more

Professor Mark Dershwitz is affiliated with the UMass Chan Medical School under the T.H. Chan School of Medicine , specifically the Department of Anesthesiology and Perioperative Medicine . He holds a PhD in Pharmacology (1982) and an MD (1982), both from Northwestern University , with postdoctoral training in anesthesiology at Massachusetts General Hospital (1984-88). His research focuses on the pharmacokinetics (PK) and pharmacodynamics (PD) of intravenous anesthetics , particularly remifentanil and morphine . He pioneered studies on remifentanil’s esterase-mediated metabolism, demonstrating its consistent short duration even in patients with hepatic or renal failure . His work on postoperative nausea and vomiting (PONV) includes the first dose-response analysis of ondansetron and a safety reevaluation of droperidol , challenging its boxed warning. Recent articles highlight his expertise in anesthetic pharmacology , with trends in AI applications in medical education (e.g., ChatGPT-4 in board exams), opioid-PONV interactions , and clinical trial design involving human volunteers. His scientific awards include the 2017 Lamar Soutter Award for Excellence in Medical Education Multiple Outstanding Medical Educator Awards (2002-2016) 2001 Distinguished Alumnus Award from Oakland University

Jennifer S. GewandterView profile

Associate Professor

• Chronic Pain
• Chemotherapy-Induced Peripheral Neuropathy (CIPN)
• Pain Clinical Trials
• +4 more

Jennifer S. Gewandter is an Associate Professor at the University of Rochester School of Medicine and Dentistry , with joint appointments in the Departments of Anesthesiology and Perioperative Medicine, Dentistry, Neurology, and Neurosurgery . Her research focuses on chronic pain, chemotherapy-induced peripheral neuropathy (CIPN), patient-reported outcomes, and clinical trial methodologies. Education: PhD in Biochemistry (2011) and MPH in Public Health (2014) from the University of Rochester; MS in Biochemistry (2008); BS in Biochemistry (2004) from SUNY Geneseo. Dr. Gewandter leads studies on CIPN treatment, pain biomarkers, and neuromodulation techniques, publishing extensively in journals like Pain and The Journal of Pain . Her work emphasizes improving clinical trial design, assay sensitivity, and patient-centered pain management. She has received awards such as the Early Career Women Faculty Leadership Development Workshop (2018) , Distributed Research Network Demonstration Project Award (2017) , and Marvel-dare F. Nutting Award (2012) , alongside predoctoral grants and fellowships. Her recent articles analyze buprenorphine initiation predictors, social disparities in pain treatment, and innovative approaches to CIPN prevention via exercise and neuromodulation. She advocates for rigorous statistical methods and patient engagement in clinical research.

Justin L. BenoitView profile

Assistant Professor

• Emergency Medicine
• Critical Care Medicine
• Cardiology
• +3 more

Dr. Justin L. Benoit is an Assistant Professor at the University of Cincinnati College of Medicine, Department of Emergency Medicine. His work focuses on prehospital medicine, cardiac arrest resuscitation, and blood-based biomarkers, with a clinical emphasis on cardiovascular disease and airway management. He is board-certified in Emergency Medicine and Emergency Medical Services by the American Board of Emergency Medicine. Bachelor's Degree: University of Maryland, College Park (Cell and Molecular Biology and Genetics) Master's Degree: University of Cincinnati (Clinical and Translational Research) Medical Degree: Case Western Reserve University Residency: University of Cincinnati (Emergency Medicine) Fellowship: University of Cincinnati (EMS and Clinical Research) His research spans sudden cardiac arrest, emergency airway management, and biomarker development, particularly in the context of OHCA and SARS-CoV-2. Recent publications highlight advancements in ECPR accessibility, cooling duration protocols, and ventilation practices. He leads multiple federally and privately funded grants, including NIH and Bill & Melinda Gates Foundation projects. Dr. Benoit's work integrates emergency medicine, critical care, and public health, emphasizing data-driven improvements in resuscitation and pandemic response. Collaborations with international researchers and institutions underscore his impact on global clinical practices.

Wolfgang GreinerView profile

Professor

• Health Economics
• Health Technology Assessment (HTA)
• Quality of Life Research
• +5 more

Prof. Dr. Wolfgang Greiner, born in 1965, is the Chair of Health Economics and Health Management at Bielefeld University's Faculty of Health Sciences. He has held this position since April 2005 and leads Working Group 5 (Health Economics and Health Management). Current roles: Dean of Faculty, Chairman of Structure and Budget Commission, Habilitation Committee member. Affiliated with Bielefeld Center for Data Science (BiCDaS). His research focuses on health technology assessment , economic evaluation of health services , quality of life metrics , and disease management frameworks . Recent projects include AI-driven clinical decision support systems for sepsis, financial burden analysis for cancer patients, and smart home emergency call system effectiveness. Key awards include the Austrian Prize for Health Economics, Hannover University Science Prize, and Medvantis Research Prize. He serves as Managing Editor of the European Journal of Health Economics and sits on scientific advisory boards for health insurers. His 2025 articles address dengue burden, AI in critical care, and dyslipidemia epidemiology. Earlier works span meningococcal vaccines, HPV disease costs, and chronic disease management in Germany.

Xiaohui XuView profile

Professor

• Environmental Epidemiology
• Air Pollution
• Maternal and Child Health
• +5 more

Xiaohui Xu is a Professor in the Department of Epidemiology & Biostatistics at Texas A&M University, specializing in environmental epidemiology. Her research focuses on the health impacts of air pollution, maternal and child health, genetic susceptibility, and spatial epidemiology. She collaborates extensively with institutions in China and the United States on population health studies. Education: PhD in Epidemiology, University of Pittsburgh (2007) MA in Environmental Health, Fudan University (2002) MD in Preventive Medicine, Zhejiang University (1999) Xu’s work explores how environmental exposures interact with genetic and pre-existing health conditions to affect outcomes in vulnerable populations. Her studies span respiratory health, cardiovascular effects of pollution, heavy metal toxicity in HIV patients, and adverse birth outcomes linked to air quality. She employs advanced exposure assessment techniques and spatial modeling. Recent publications highlight her focus on prenatal particulate matter exposure, gestational diabetes, ozone health effects, and pollution mitigation strategies. Collaborative trials include air purifier efficacy studies and community-based interventions for asthma management. Her research bridges environmental science, public health, and clinical epidemiology. Xu holds appointments in environmental health policy and contributes to understanding pollution’s role in chronic disease progression. Her work informs regulatory frameworks and health interventions in high-risk populations, including agricultural communities and urban asthma sufferers.

Xiaowei WangView profile

Professor

• Molecular Imaging
• Nanotherapeutics
• Cardiovascular Disease
• +3 more

Professor Xiaowei Wang is a leading academic at the Baker Heart and Diabetes Institute , where she heads the Molecular Imaging and Nanotherapeutics laboratory and co-leads the Heart Attack Program and Centre for Cardiometabolic mRNA Therapy . She holds adjunct and honorary academic appointments at the University of Melbourne, La Trobe University, Monash University, Swinburne University, and Torrens University. Professor Wang earned her PhD from Monash University and is a Fellow of the Australian Academy of Health Sciences (FAHA), Cardiac Society of Australia and New Zealand (FCSANZ), and European Society of Cardiology (FESC). Her research integrates physics, chemistry, biology, and biotechnology to develop clinical-ready diagnostic and therapeutic solutions for cardiovascular disease. Her work focuses on preclinical molecular imaging using advanced technologies like MRI, PET, and photoacoustic imaging to enable early diagnosis and real-time monitoring of treatments. She pioneers mRNA therapeutics and vaccines delivered via micro- and nano-particles to prevent heart attacks, strokes, and inflammation with minimal side effects. Key trends in her publications highlight targeted drug delivery , thrombosis prevention , Nanotherapeutics , and translational cardiovascular research . Her studies often explore the intersection of molecular imaging , biomedical engineering , and clinical applications . Scientific awards and recognitions: National Heart Foundation Future Leader Fellowship Level 2 Baker Institute Sir Laurence Muir Prize World Molecular Imaging Society Mid Career Award Inaugural Fellow of the Australian Society of Molecular Imaging National Heart Foundation Paul Korner Innovation Award Inaugural Women of Colour in STEM Award AVBS Achievement and Career Development Award 40 Under 40 Most Influential Asian-Australian Award Finalist Professor Wang is also deeply committed to equity and mentorship, chairing the Baker Institute’s Mentoring Committee and serving on leadership teams for the Women in Molecular Imaging Network and the Gender Equity and Diversity Committee. She has received over 27 national and international travel grants, 18 research prizes, and 14 Young Investigator Awards, underscoring her impact in the field.

Urshila SriramView profile

Assistant Professor

• Nutrition
• Health Equity
• Community-Based Health Interventions
• +2 more

Urshila Sriram is an Assistant Professor in the Department of Nutrition at Simmons University, specializing in community-based programs for nutrition and health equity. She holds a PhD in Nutritional Sciences and an MSPH in Human Nutrition from Cornell University and Johns Hopkins School of Public Health, respectively. Education: PhD in Nutritional Sciences (Cornell), MSPH in Human Nutrition (Johns Hopkins), BS in Biochemistry (McGill) Her research focuses on nutrition and health equity , community-based interventions , and food security . She emphasizes cultural humility and structural inequities in dietetics practice. Her work includes evaluating civic engagement programs for rural health promotion and developing NIH-funded health intervention measures. Dr. Sriram’s teaching philosophy prioritizes experiential learning and student-centered growth . Courses taught include NUTR 452 (Program Planning), NUTR 490 (Nutrition Research), and LCIS 201 (Health Promotion). She mentors students in nutrition equity and policy. Community engagement highlights: Co-Chair for Food Is Medicine Massachusetts , co-advisor for Simmons Nutrition Diversity Mentorship Program, and member of Diversify Dietetics Mentorship Program . She advocates for health equity through civic action and curriculum innovation.

John Bjarne HansenView profile

Professor

• Venous Thromboembolism
• Clinical Epidemiology
• Cardiovascular Medicine
• +5 more

Professor John Bjarne Hansen is a prominent researcher in the field of venous thromboembolism (VTE) at the Department of Clinical Medicine, UiT The Arctic University of Norway. He serves as Research Group Leader of Thrombosis Research (TREC) and Head of Unit at the Thrombosis Research Center (TREC), Medical Clinic, University Hospital of Northern Norway. Education: Cand.med (MD), Universitetet i Tromsø (1989) Dr. med (PhD in Cardiovascular Medicine), Universitetet i Tromsø (1997) Hansen's research focuses on clinical epidemiology and risk factors for venous thromboembolism, diagnostic and predictive biomarkers for VTE, and the pathophysiology of thrombotic events. His work spans multiple projects including PREVENT, Mission-VTE, Genetics and VTE, Biomarkers of VTE risk, and Cancer-associated VTE. He has contributed significantly to understanding the complex interplay between genetic factors, lifestyle, and comorbidities in VTE development. His recent publications demonstrate a strong focus on biomarkers for VTE prediction, with numerous 2024-2025 articles examining genetic, molecular, and clinical risk factors. His research utilizes large population studies like the HUNT and Tromsø studies to identify novel predictors and understand gender differences in VTE risk. Hansen has made substantial contributions to thrombosis research through his leadership of the Thrombosis Research Center (TREC) and through active participation in international collaborations. His work bridges basic science and clinical application, with emphasis on translating research findings into improved risk prediction and prevention strategies for venous thromboembolism. Mentorship and Academic Leadership: Primary supervisor for 35 completed PhD theses Co-supervisor for 5 completed PhD theses Currently supervising 7 PhD students as primary supervisor and 6 as co-supervisor Mentored 13 postdoctoral researchers (10 former, 3 current) He has held various academic positions since 1991, progressing from doctoral student to full professor, with a visiting professorship at The Scripps Research Institute (2008-2009). From 2007-2008, he served as Pro-Dean for Research at the Faculty of Health Sciences.

Janet V. CrossView profile

Associate Professor

• Molecular Mechanisms of Cancer Chemoprevention
• Anti-Inflammatory Benefits of Dietary Nutrient Compounds
• Biochemistry
• +1 more

Janet V. Cross, Ph.D., is an Associate Professor in the Department of Pathology at the University of Virginia Health System (UVA Health). Her research focuses on the molecular mechanisms of cancer chemoprevention and the anti-inflammatory benefits of dietary nutrient compounds, particularly isothiocyanates found in cruciferous vegetables like broccoli. Her work investigates how bioactive nutrients interact with cellular proteins to prevent tumor development and modulate inflammatory diseases such as rheumatoid arthritis and asthma. Using proteomics and in vitro models, she explores the role of isothiocyanates in signal transduction, apoptosis, and inflammation, linking these processes to cancer risk and therapeutic targets. Publications highlight her contributions to understanding how dietary compounds affect pathogenesis, including studies on Helicobacter pylori-related gastritis, air pollution's impact on brain immunity, and the role of macrophage migration inhibitory factor (MIF) in tumor progression. Her research bridges nutritional biochemistry and pathology, emphasizing the intersection of inflammation and cancer chemoprevention.

Xiaowen BaiView profile

Professor

• Stem Cell Biology
• Neurodegeneration
• Cardiotoxicity
• +5 more

Xiaowen Bai, MD, PhD, is a Professor in the Department of Cell Biology, Neurobiology and Anatomy at the Medical College of Wisconsin. His research focuses on leveraging stem cells to model neurodegenerative diseases and cardiac disorders, with a particular emphasis on non-coding RNAs, mitochondria, and environmental stressors like anesthetics and alcohol. He holds a leadership role as Executive Director of Hematology at the World Federation of Chinese Medicine Societies (WFCMS). Education: MD, Shanxi Medical University (1993) PhD, Beijing University Stem Cell Center (2004) Postdoctoral Training, University of Texas MD Anderson Cancer Center (2007) Research Interests: Neurodegeneration mechanisms involving microRNAs, lncRNAs, and mitochondrial dysfunction Stem cell-based therapies for myocardial regeneration Diabetic cardiomyopathy pathogenesis and cardioprotection 3D organoid models for studying anesthetic and alcohol neurotoxicity Recent Work: Recent publications emphasize translational studies using human-induced pluripotent stem cell (iPSC)-derived models to investigate alcohol-induced brain injury, anesthetic neurotoxicity, and cardiac fibrosis. His lab also explores immunomodulatory pathways and redox signaling in inflammatory diseases. Labs/Teams: The Bai Lab develops novel in vitro models for disease modeling and drug testing, focusing on cerebral organoids and cardiac organoids to bridge basic research and clinical applications.

Samaya Javed AnumuduView profile

Associate Professor

• Public Policy and Advocacy
• Home Dialysis
• Chronic Kidney Disease
• +3 more

Dr. Samaya Javed Anumudu is an Associate Professor of Medicine-Nephrology at Baylor College of Medicine in Houston, TX. She completed her Internal Medicine residency at Cone Health (Greensboro, NC) as Chief Resident, followed by a nephrology fellowship at Baylor College of Medicine with a clinical focus on Public Policy. Board certified in Internal Medicine and Nephrology, she specializes in home dialysis, chronic/end-stage kidney disease, medical education, and quality improvement. Dr. Anumudu directs home dialysis services at Baylor Medicine and practices across multiple Houston facilities, including CHI Baylor St. Luke’s Hospital, Houston Methodist, Ben Taub Hospital, and Harris Health System clinics. She actively participates in professional organizations like the Renal Physicians Association (RPA Board of Directors, Vice Chair of Education Committee) and the American Society of Nephrology (Public Policy Committee). Her research focuses on public policy impacting kidney care, patient outcomes in CKD, and dialysis access equity. Notable awards include the 2020 Women of Excellence Award, 2021 Early Career Faculty Award, and Distinguished Educator Award. She is also an Inclusion and Equity Ambassador at Baylor College of Medicine and a member of The Gold Humanism Honor Society.

Jacqueline ColeView profile

Associate Professor

• Rehabilitation Engineering
• Regenerative Medicine
• Bone Mechanics
• +5 more

Jacqueline Cole is an Associate Professor in the Department of Biomedical Engineering at North Carolina State University, part of the College of Engineering. Her research focuses on bone mechanics, musculoskeletal development, and regenerative therapies for conditions like brachial plexus birth injury and stroke-related bone deficits. She leads the Orthopaedic Mechanobiology Lab, which employs advanced imaging (e.g., CT, microscopy) and computational modeling to study bone-tissue interactions. Cole teaches courses in orthopedic biomechanics and bone mechanobiology. Education: Ph.D. (2007), M.S. (2004) Mechanical Engineering from Cornell University; B.S. (2001) Mechanical Engineering from Auburn University. Research interests include stroke and obesity effects on bone, brachial plexus injury recovery, and tissue engineering. Awards span teaching (NC State Alumni Outstanding Teacher Award) and research mentorship (Michael Dickey Award). She has pioneered studies on bone-vascular interactions and suture materials for tendon repair. Her lab’s long-term goals involve developing therapies to prevent musculoskeletal dysfunction via mechanobiological approaches. Grants include NIH TIGRR and K12 funding. Recent work explores ischemic stroke’s impact on osteovascular structure and brachial plexus injury’s effects on joint morphology.